News & Events
Relevant stories and topics seeded from third party sources & Linkedin
August 29th, 2022
NEW YORK, August 29, 2022 — A first-of-its-kind patient cohort platform will soon be available to UK and US researchers struggling to recruit patients with interstitial lung disease (ILD), such as pulmonary fibrosis and progressing fibrosis resulting from COVID-19. UK-based company uMed announced the launch of the Access-ILD/PF Cohort at the sixth annual Idiopathic Pulmonary…
October 5th, 2021
An article published in the Journal of Clinical Studies describing the benefits of uMed in clinical trial recruitment
September 9th, 2021
An automated patient recruitment platform (ARP) could help researchers recruit patients significantly faster into clinical studies across diverse disease areas, helping researchers identify new treatments for diseases more quickly, tech platform creator uMed says.
March 23rd, 2021
Pharma Business International features uMed CEO Matt Wilson. He discusses uMed’s growth as a health technology company and the importance of building trust with all stakeholders.
November 30th, 2020
uMed raises $4.8m in venture capital funding to help healthcare providers participate in more clinical studies.
April 16th, 2020
Growth Business highlights 3 tech start-ups actively fighting the Covid-19 pandemic that are open for investment to fund further research and development.
February 14th, 2020
We are excited to share uMed are in the Top 20 of the BusinessCloud’s 100 HealthTech Pioneers ranking for 2020! Well done to the uMed team for all their continued hard work!
January 30th, 2020
uMed’s Ian Wootton joined the debate on Integrated Healthcare, hosted by the UKs Department for International Trade at Arab Health.